Literature DB >> 16316593

Theories concerning the pathogenesis of the acute charcot foot suggest future therapy.

William J Jeffcoate1.   

Abstract

The acute Charcot foot is characterized by bone fracture and dislocation, and is a rare complication of distal symmetrical neuropathy in diabetes. The cause is unknown, but it cannot be attributed solely to loss of protective sensation. However, recent advances in understanding the mechanisms of osteoclast activation have suggested that the key abnormality may lie in an enhanced inflammatory response to injury, which is itself linked to increased bone lysis. The recognition that the acute Charcot foot is essentially an inflammatory arthropathy suggests new options for the management of this potentially devastating condition.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16316593     DOI: 10.1007/s11892-005-0050-z

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  47 in total

Review 1.  Recognition and management of acute neuropathic (Charcot) arthropathies of the foot and ankle.

Authors:  D R Sinacore; N C Withrington
Journal:  J Orthop Sports Phys Ther       Date:  1999-12       Impact factor: 4.751

2.  Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing.

Authors:  T Kon; T J Cho; T Aizawa; M Yamazaki; N Nooh; D Graves; L C Gerstenfeld; T A Einhorn
Journal:  J Bone Miner Res       Date:  2001-06       Impact factor: 6.741

3.  Long-term follow-up in diabetic Charcot feet with spontaneous onset.

Authors:  J Fabrin; K Larsen; P E Holstein
Journal:  Diabetes Care       Date:  2000-06       Impact factor: 19.112

Review 4.  RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function.

Authors:  Michael Schoppet; Klaus T Preissner; Lorenz C Hofbauer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-04-01       Impact factor: 8.311

5.  Dorsiflexion metatarsal osteotomy for treatment of recalcitrant diabetic neuropathic ulcers.

Authors:  J E Fleischli; R B Anderson; W H Davis
Journal:  Foot Ankle Int       Date:  1999-02       Impact factor: 2.827

6.  Mönckeberg's sclerosis after sympathetic denervation in diabetic and non-diabetic subjects.

Authors:  F D Goebel; H S Füessl
Journal:  Diabetologia       Date:  1983-05       Impact factor: 10.122

7.  Impaired fracture healing in the absence of TNF-alpha signaling: the role of TNF-alpha in endochondral cartilage resorption.

Authors:  L C Gerstenfeld; T J Cho; T Kon; T Aizawa; A Tsay; J Fitch; G L Barnes; D T Graves; T A Einhorn
Journal:  J Bone Miner Res       Date:  2003-09       Impact factor: 6.741

8.  Normal blood flow response and vasomotion in the diabetic Charcot foot.

Authors:  S A Shapiro; K B Stansberry; M A Hill; M D Meyer; P M McNitt; B A Bhatt; A I Vinik
Journal:  J Diabetes Complications       Date:  1998 May-Jun       Impact factor: 2.852

9.  Pattern of diabetic neuropathic arthropathy associated with the peripheral bone mineral density.

Authors:  S A Herbst; K B Jones; C L Saltzman
Journal:  J Bone Joint Surg Br       Date:  2004-04

10.  Medial arterial calcification and diabetic neuropathy.

Authors:  M E Edmonds; N Morrison; J W Laws; P J Watkins
Journal:  Br Med J (Clin Res Ed)       Date:  1982-03-27
View more
  11 in total

1.  [Tibiotalocalcaneal corrective arthrodesis in Charcot arthropathy of the ankle with a retrograde nail].

Authors:  J von Recum
Journal:  Oper Orthop Traumatol       Date:  2015-04-10       Impact factor: 1.154

2.  Charcot osteoarthropathy in diabetes: A brief review with an emphasis on clinical practice.

Authors:  Evanthia Gouveri; Nikolaos Papanas
Journal:  World J Diabetes       Date:  2011-05-15

Review 3.  Neuropathic osteoarthropathy with and without superimposed osteomyelitis in patients with a diabetic foot.

Authors:  Antonio Leone; Victor N Cassar-Pullicino; Alessia Semprini; Laura Tonetti; Nicola Magarelli; Cesare Colosimo
Journal:  Skeletal Radiol       Date:  2016-02-17       Impact factor: 2.199

4.  An overview of conservative treatment options for diabetic Charcot foot neuroarthropathy.

Authors:  Crystal L Ramanujam; Zacharia Facaros
Journal:  Diabet Foot Ankle       Date:  2011-05-11

5.  Prevalence of polymorphisms in OPG, RANKL and RANK as potential markers for Charcot arthropathy development.

Authors:  Bożena Bruhn-Olszewska; Anna Korzon-Burakowska; Grzegorz Węgrzyn; Joanna Jakóbkiewicz-Banecka
Journal:  Sci Rep       Date:  2017-03-29       Impact factor: 4.379

6.  Rapid glycemic regulation in poorly controlled patients living with diabetes, a new associated factor in the pathophysiology of Charcot's acute neuroarthropathy.

Authors:  Dured Dardari; Georges Ha Van; Jocelyne M'Bemba; Francois-Xavier Laborne; Olivier Bourron; Jean Michel Davaine; Franck Phan; Fabienne Foufelle; Frédéric Jaisser; Alfred Penfornis; Agnes Hartemann
Journal:  PLoS One       Date:  2020-05-21       Impact factor: 3.240

7.  Impact of the Rapid Normalization of Chronic Hyperglycemia on the Receptor Activator of Nuclear Factor-Kappa B Ligand and the Osteoprotegerin System in Patients Living with Type 2 Diabetes: RANKL-GLYC Study.

Authors:  Dured Dardari; Claire Thomas; Francois-Xavier Laborne; Caroline Tourte; Elodie Henry; Megane Erblang; Stéphanie Bourdon; Alfred Penfornis; Philippe Lopes
Journal:  Medicina (Kaunas)       Date:  2022-04-18       Impact factor: 2.948

8.  Etiology, pathophysiology and classifications of the diabetic Charcot foot.

Authors:  Nikolaos Papanas; Efstratios Maltezos
Journal:  Diabet Foot Ankle       Date:  2013-05-21

Review 9.  Charcot foot and ankle with osteomyelitis.

Authors:  Ryan Donegan; Bauer Sumpio; Peter A Blume
Journal:  Diabet Foot Ankle       Date:  2013-10-01

10.  Fracture of the Bone Inducing Its Necrosis as the End Point in the Evolution of Untreated Neuroarthropathy.

Authors:  Dured Dardari; Alfred Penfornis
Journal:  Medicina (Kaunas)       Date:  2021-12-22       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.